AJDRAJNR - American Journal of Neuroradiology

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by He, J.
Right arrow Articles by Mannon, L. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by He, J.
Right arrow Articles by Mannon, L. J.

ARTICLE

Enhancing Patterns in Multiple Sclerosis: Evolution and Persistence

Juan Hea, Robert I. Grossman,a, Yulin Gea and Lois J. Mannona

a From the Department of Radiology, Hospital of the University of Pennsylvania, 3400 Spruce Street, Philadelphia, PA 19104-4283.

BACKGROUND AND PURPOSE: Contrast enhancement on MR images of patients with multiple sclerosis (MS) is known to be associated with abnormalities of the blood-brain barrier (BBB). However, little is known about diagnostic patterns and common features of enhanced MS lesions. This study was designed to evaluate initial enhancement patterns, changes in these enhancing patterns, and duration of enhancement in a cohort of patients with MS.

METHODS: Twenty-five patients with clinically definite MS were studied retrospectively. The appearance of enhancing lesions and sequential changes in the appearance on axial contrast-enhanced spin-echo images were evaluated. The enhancing lesions were classified as nodular, ringlike, or "other" (eg, arclike).

RESULTS: Of 301 new enhancing lesions, 205 (68%) showed nodular enhancement, 70 (23%) a ring pattern, and 26 (9%) a pattern neither nodular nor ringlike (eg, arclike). Two hundred eighty (93%) of 301 enhancing lesions disappeared within 6 months, and seven (2%) lesions showed persistent enhancement longer than 6 months. The other 14 (5%) lesions, which disappeared by the time of the next scan, were excluded, because the course between two examinations was longer than 6 months. Of nine persisting nodular enhancing lesions on the follow-up images, seven were decreased in size, whereas all of two persisting ringlike enhancing lesions on the follow-up images were larger than before.

CONCLUSION: Nodular enhancement is the predominant enhancement pattern for new MS lesions, and the temporal course of enhancement is usually shorter than 6 months. The appreciation of the evolution of MS-enhanced lesions aids in both identifying new MS lesions and distinguishing these lesions from other pathologic entities. This may be helpful in clinically evaluating the stage of MS lesions.




This article has been cited by other articles:


Home page
Am. J. Neuroradiol.Home page
D.S. Meier, H.L. Weiner, and C.R.G. Guttmann
MR Imaging Intensity Modeling of Damage and Repair In Multiple Sclerosis: Relationship of Short-Term Lesion Recovery to Progression and Disability
AJNR Am. J. Neuroradiol., November 1, 2007; 28(10): 1956 - 1963.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
Y. Ge
Multiple Sclerosis: The Role of MR Imaging
AJNR Am. J. Neuroradiol., June 1, 2006; 27(6): 1165 - 1176.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
A. Minneboo, B. M. J. Uitdehaag, H. J. Ader, F. Barkhof, C. H. Polman, and J. A. Castelijns
Patterns of enhancing lesion evolution in multiple sclerosis are uniform within patients
Neurology, July 12, 2005; 65(1): 56 - 61.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
C. A. Given II, B. S. Stevens, and C. Lee
The MRI Appearance of Tumefactive Demyelinating Lesions
Am. J. Roentgenol., January 1, 2004; 182(1): 195 - 199.
[Full Text] [PDF]


Home page
NeurologyHome page
F. Cotton, H. L. Weiner, F. A. Jolesz, and C. R.G. Guttmann
MRI contrast uptake in new lesions in relapsing-remitting MS followed at weekly intervals
Neurology, February 25, 2003; 60(4): 640 - 646.
[Abstract] [Full Text] [PDF]